<DOC>
	<DOCNO>NCT00841633</DOCNO>
	<brief_summary>The purpose study test feasibility trial induce hypertension improve neurological outcome patient subarachnoid haemorrhage develop serious complication `` delayed cerebral ischemia '' , ass whether induced hypertension result improve cerebral blood flow ( CBF ) measure mean perfusion-CT .</brief_summary>
	<brief_title>Induced Hypertension Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid Haemorrhage : Feasibility Study</brief_title>
	<detailed_description>Background : Delayed cerebral ischaemia ( DCI ) major complication aneurysmal subarachnoid haemorrhage ( SAH ) . The proportion SAH patient develop DCI around 30 % . Many centre around world use induced hypertension , alone combination haemodilution hypervolaemia , call Triple-H , standard therapy treatment DCI , efficacy induced hypertension reduce DCI base case series , randomise clinical trial . Objective : To test feasibility trial induce hypertension improve neurological outcome , ass whether induced hypertension result improve cerebral blood flow ( CBF ) measure mean perfusion-CT. Study design : A randomised control feasibility trial . Study population : Patients admit UMC Utrecht recent SAH , develop DCI . Twenty four patient randomised standard care group one intervention group . Interventions : Patients intervention group treat induced hypertension ( 30 mmHg increase mean arterial pressure ) order improve CBF . Patients standard care group treat accord standardised SAH treatment protocol UMC Utrecht monitor mean arterial pressure prevent drop mean arterial pressure 80 mmHg . 24-36 hour instalment treatment , perfusion CT scan perform . In patient show neurological improvement within 24 hour start hypertensive treatment , administration norepinephrine taper . In patient show improvement , induced hypertension continue total period 72 hour , norepinephrine gradually taper . Measurement CBF perform participant perfusion CT-scanning brain beginning study ( part regular patient care ) 24-36 hour start . Main outcome measurement : The number patient diagnosis DCI SAH , intervention ( induced hypertension ) adequately perform , include within 18 month start study .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Brain Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Norepinephrine</mesh_term>
	<criteria>1 . Admission UMC Utrecht . 2 . Age 18 year . 3 . Aneurysmal SAH , demonstrate CTangiography cerebral angiography , onset less 72 hour admission . 4 . A level consciousness correspond Glasgow Coma Sum Score 8 , patient low Glasgow Coma Sum Scores , assessment deterioration may less reliable . 1 . Symptomatic aneurysm yet treat coil clipping . Coexisting asymptomatic cerebral aneurysm reason exclusion , since previous study find increase risk rupture aneurysms hypertensive hypervolemic treatment . ( 26 ) 2 . Coexisting severe head injury . 3 . A history cardiac rhythm disorder , necessitate medical treatment . 4 . A history leave ventricular pump failure , necessitate medical treatment . 5 . Pregnancy . 6 . Known allergy CTcontrast agent . 7 . Renal failure , define serum creatinine &gt; 150 Âµmol/l , risk contrast nephropathy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>subarachnoid hemorrhage</keyword>
	<keyword>ischemia</keyword>
	<keyword>vasospasm</keyword>
	<keyword>CT</keyword>
	<keyword>perfusion</keyword>
	<keyword>induced hypertension</keyword>
	<keyword>delay cerebral ischemia</keyword>
</DOC>